Home › Interstitial Lung Diseases › Michigan › Ann Arbor
Interstitial Lung Diseases clinical trials in Ann Arbor, MI
11 studies for Interstitial Lung Diseases are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RecruitingPhase 3
- University of Michigan, Ann Arbor
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Ann Arbor
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Ann Arbor
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- University of Michigan - Michigan Medicine, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Michigan, Ann Arbor
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
RecruitingObservational study
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- University of Michigan, Ann Arbor
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- University of Michigan, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
RecruitingPhase 2
- Galderma Investigational Site # 8743, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RecruitingObservational study
- University of Michigan, Ann Arbor
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Houston, TX13 studies
- Durham, NC13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Aurora, CO11 studies
- Birmingham, AL10 studies
- Boston, MA10 studies
- Salt Lake City, UT10 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.